Sertraline Heart Study

Phase 4

• Conditions: Heart disease; Mental Health - Anxiety; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12606000329561
• Lead Sponsor: Mood Research Foundation (WA) Inc

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-08-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Abnormal echocardiogram with history of any cardiac symptoms.

Exclusion Criteria

Malignancy & Psychotrophics.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in anxiety[Measured at 6 weeks and again at 12 weeks]

Secondary Outcome Measures

Name	Time	Method
Reduction in depression, reduction in fatigue, increase in effort tolerance and increase in quality of life.[All will be measured at 6 and 12 weeks.]